HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)

HeartSciences' (HSCS) quarterly Other Non-Current Liabilities came in at $32103.0 in Q4 2024, down 84.54% on a QoQ basis from $207592.0 in Q3 2023.

HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends

HeartSciences (HSCS) has 3 years of Other Non-Current Liabilities data on file, last reported at $32103.0 in Q4 2024.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $32103.0 in Q4 2024, while the trailing twelve-month figure through Oct 2024 was $32103.0 (changed N/A YoY) and the FY2023 annual result came in at $187450.0, down 19.5% from the prior year.
Other Non-Current Liabilities fell to $32103.0 in Q4 2024, from $207592.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $232868.0 in Q2 2022 to a low of $32103.0 in Q4 2024.
A 3-year average of $166926.3 and a median of $195514.0 in 2023 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 50.46% in 2023, down 19.5% in 2023.
Tracing HSCS's Other Non-Current Liabilities over 3 years: stood at $137967.0 in 2022, then soared by 50.46% to $207592.0 in 2023, then plunged by 84.54% to $32103.0 in 2024.
The last three Other Non-Current Liabilities figures came in at $32103.0 (Q4 2024), $207592.0 (Q3 2023), and $187450.0 (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	HeartSciences	7.06 Mn	5.36 Mn	-

Download Data